Anticancer Research 2015-04-01

Novel in vitro platform to investigate myotube atrophy.

Christopher Oelkrug, Katharina Horn, Gustavo R Makert, Andreas Schubert

Index: Anticancer Res. 35(4) , 2085-91, (2015)

Full Text: HTML

Abstract

The electrical current exclusion (ECE) principle provides an alternative to common methods of cell diameter measurement and especially in atrophy and cancer associated cachexia research. C2C12 myoblasts were differentiated into myotubes and treated with 100 μM dexamethasone to induce atrophy in vitro. Subsequently, they were incubated for 24 h with media containing different concentrations of curcumin and/or branched-chain amino acids (BCAAs) in order to counteract atrophy. After treatment with curcumin, an increase in cell diameter was detectable; the highest increase with 13.9 ± 0.4% was seen with 10 μM curcumin. The combination of curcumin and BCAAs showed an increase of 13.4 ± 1.2 %. Cell diameter measurement via the ECE showed that curcumin, and curcumin in combination with BCAAs, were able to restore atrophic C2C12 myotubes. Therefore, the application of ECE in muscle atrophy and also cancer-associated cachexia research allows rapid screening of novel compounds in order to test their efficacy in vitro.Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.


Related Compounds

Related Articles:

Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release.

2014-11-01

[J. Pharm. Sci. 103(11) , 3764-71, (2014)]

Enhancing the anti-inflammatory activity of chalcones by tuning the Michael acceptor site.

2015-03-14

[Org. Biomol. Chem. 13(10) , 3040-7, (2015)]

An antifungal mechanism of curcumin lies in membrane-targeted action within Candida albicans.

2014-11-01

[IUBMB Life 66(11) , 780-5, (2015)]

Identification of the cellular mechanisms that modulate trafficking of frizzled family receptor 4 (FZD4) missense mutants associated with familial exudative vitreoretinopathy.

2014-06-01

[Invest. Ophthalmol. Vis. Sci. 55(6) , 3423-31, (2014)]

Improved plasma membrane expression of the trafficking defective P344R mutant of muscle, skeletal, receptor tyrosine kinase (MuSK) causing congenital myasthenic syndrome.

2015-03-01

[Int. J. Biochem. Cell Biol. 60 , 119-29, (2015)]

More Articles...